Bausch Health Cos Profit Margin 2006-2019 | BHC

Current and historical gross margin, operating margin and net profit margin for Bausch Health Cos (BHC) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Bausch Health Cos net profit margin as of September 30, 2019 is -7.25%.
Bausch Health Cos Annual Profit Margins
Bausch Health Cos Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $10.259B $8.380B
Bausch Health Companies Inc. develops and distributes drugs. It develops drugs for unmet medical needs in central nervous system disorders and distributes generic and branded generic drugs primarily in Latin America and Eastern Europe. Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals, is based in NJ, United States.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $61.181B 11.15
Teva Pharmaceutical Industries (TEVA) Israel $10.834B 4.41
Mylan (MYL) United States $9.956B 4.47
Dr Reddy's Laboratories (RDY) India $6.698B 17.57
ASPEN PHARMACR (APNHY) South Africa $3.391B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.198B 11.59
Amphastar Pharmaceuticals (AMPH) United States $0.888B 46.15
Homology Medicines (FIXX) United States $0.800B 0.00
Voyager Therapeutics (VYGR) United States $0.518B 0.00
Akorn (AKRX) United States $0.473B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.442B 0.00
Assembly Biosciences (ASMB) United States $0.428B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.287B 0.39
Adamas Pharmaceuticals (ADMS) United States $0.180B 0.00
Sol-Gel Technologies (SLGL) Israel $0.158B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.131B 0.00
CymaBay Therapeutics (CBAY) United States $0.120B 0.00
Teligent (TLGT) United States $0.033B 0.00